Uploaded August 2026 | Updated September 2026, 3 weeks ago

---

Cheaper weight-loss drugs were expected to take off in India. But despite GLP-1s costing as little as $14 a month, demand has been slower than expected. From stigma to hesitant doctors, Satviki Sanjay explains why price isn’t the only barrier.
----------
Like this video? Subscribe youtube.com/@Bloomberg-News

Bloomberg News is the first word in business news. Visit bloomberg.com for the latest on global business, markets and more.
Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months: bloomberg.com/subscriptions?in_source=YoutubeOriginals

Bloomberg on YouTube:
youtube.com/@business
youtube.com/@markets
youtube.com/@BloombergTechnology
youtube.com/@BloombergPodcasts

Connect with us on social:
instagram.com/bloombergbusiness
linkedin.com/company/bloomberg-news
tiktok.com/@bloombergbusiness
facebook.com/bloombergbusiness